Advertisement
Canada markets closed

  • S&P/TSX

    22,290.62
    +31.15 (+0.14%)
     

  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • CAD/USD

    0.7282
    -0.0039 (-0.53%)
     

  • CRUDE OIL

    78.38
    0.00 (0.00%)
     

  • Bitcoin CAD

    86,524.65
    -628.93 (-0.72%)
     

  • CMC Crypto 200

    1,306.46
    -58.66 (-4.30%)
     

  • GOLD FUTURES

    2,323.20
    -1.00 (-0.04%)
     

  • RUSSELL 2000

    2,064.65
    +3.97 (+0.19%)
     

  • 10-Yr Bond

    4.4630
    -0.0260 (-0.58%)
     

  • NASDAQ futures

    18,200.50
    +1.00 (+0.01%)
     

  • VOLATILITY

    13.23
    -0.26 (-1.93%)
     

  • FTSE

    8,313.67
    +100.18 (+1.22%)
     

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • CAD/EUR

    0.6771
    -0.0021 (-0.31%)
     

Tetraphase (TTPH) Crumbles: Stock Tanks by 15%

Zacks Equity Research



Tetraphase Pharmaceuticals, Inc. (TTPH) saw a big move last session, as the company’s shares fell by almost 15% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for TTPH as the stock is now up around 12% in the past one-month time frame.

This clinical-stage biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks and the consensus for loss hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.

TTPH currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the Med-Drugs industry include Ampio Pharmaceuticals, Inc. (AMPE), Cempra, Inc. (CEMP) and Enanta Pharmaceuticals, Inc. (ENTA). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




TETRAPHASE PHARMACEUTICALS INC (TTPH): Free Stock Analysis Report

AMPIO PHARMACEUTICALS INC (AMPE): Free Stock Analysis Report

CEMPRA INC (CEMP): Free Stock Analysis Report

ENANTA PHARMACEUTICALS INC (ENTA): Free Stock Analysis Report


Zacks Investment Research